Reminyl Related Clinical Trials
The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning [Active, not recruiting]
A Study of the Safety and Effectiveness of Galantamine Hydrobromide (REMINYLŪ) in Patients With Alzheimer's Disease [Completed]
A Single Dose, Cross-Over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy Volunteers [Completed]
A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease [Completed]
A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia [Completed]
Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (ReminylŪ) [Recruiting]
A Double-Blind Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder [Completed]
A Randomized, Double-Blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease [Completed]
A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment [Completed]
Efficacy and Safety of Galantamine for Improving Dysfunction in People With Bipolar Disorder [Not yet recruiting]
Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease [Completed]
The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type [Completed]
Galantamine Versus Placebo in Childhood Autism [Completed]
Galantamine Effects on Cognitive Function in Abstinent Cocaine Users [Recruiting]
Treatment of Tardive Dyskinesia With Galantamine [Completed]
Galantamine for Cognitive Deficits in Schizophrenia [Completed]
Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease [Completed]
A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease [Completed]
Long-Term Safety and Efficacy of Galantamine in Alzheimer's Disease [Completed]
A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease [Completed]
Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies [Completed]
A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease [Completed]
A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease [Completed]
Evaluation of Galantamine in the Treatment of Alzheimer's Disease [Completed]
A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia [Completed]
A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment [Completed]
A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment [Completed]
A Study of the Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia. [Completed]
Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study [Active, not recruiting]
Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation [Completed]
The Use of Galantamine and CDP-Choline to Treat Adults With Schizophrenia [Recruiting]
Efficacy of Galantamine to Treat Schizophrenia [Recruiting]
Safety Study of Galantamine in Tic Disorders [Terminated]
Galantamine Augmentation of Escitalopram for Treatment of Depression [Terminated]
Galantamine for Cognition in People With Schizophrenia [Active, not recruiting]
Galantamine Executive Function in Parkinson's Disease [Active, not recruiting]
A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder [Active, not recruiting]
A Double-Blind, Placebo-Controlled, 2-Year Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease. [Recruiting]
Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia [Completed]
A Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia [Completed]
An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms [Completed]
A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease. [Completed]
An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease. [Completed]
Galantamine-CR and Cognitive Dysfunction in Bipolar Disorder [Completed]
An Observational Study of the Vital Status Data of Patients (Living or Deceased) Who Participated in Three Previous Studies of Galantamine for the Treatment of Mild Cognitive Impairment [Completed]
Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients [Terminated]
Alzheimer and Sleep [Not yet recruiting]
An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-Month Period [Active, not recruiting]
Galantamine in the Treatment of Post-Traumatic Headache [Recruiting]
The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD) [Active, not recruiting]
Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke [Completed]
Continuous Arterial Spin Labeling (CASL) MRI for Monitoring and Prediction of Drug Therapy in Alzheimers Disease (AD) [Recruiting]
Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease [Recruiting]
Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment [Completed]
Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease [Completed]
Mifepristone as Adjunctive Therapy in Alzheimer's Disease [Terminated]
A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease [Completed]
|
